Phase 2b Study of GSK4532990 in Adults With NASH

Clinical trial NCT05583344 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05583344
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease

Start date: 2023-01-02
Primary completion: 2026-01-31
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.